Scienmag

SEPTEMBER 11, 2020

Better stress management is beneficial to newborns A group of researchers from Charité – Universitätsmedizin Berlin have been able to show that maternal psychological wellbeing during pregnancy has a positive effect on newborn infants. Results from […].

Research 40

Research Medicine 40

The Pharma Data

OCTOBER 21, 2020

. “Nurses make substantial, often unrecognized, contributions to public health during pregnancy, and during and following birth,” said study author Audrey Lyndon, assistant dean for clinical research at NYU Rory Meyers College of Nursing in New York City. © 2020 HealthDay. All rights reserved. Posted: October 2020. Source link.

Nurses 52

Nurses Clinical Research Research 52

pharmaphorum

JUNE 10, 2022

Their retrospective study looked at more than 7,500 infants delivered during the pandemic, including 222 born to mothers with a positive COVID-19 test during pregnancy. ” The post Is COVID in pregnancy linked to infant development issues? “We need a bigger study to confirm the exact extent of the difference.”

Development 104

Development Genetics Scientist Research 104

Drug Discovery World

AUGUST 7, 2023

Until now, treatment for PPD was only available as an IV injection given by a health care provider in certain health care facilities.

Drugs 52

Drugs Production Development Research 52

The Pharma Data

DECEMBER 28, 2020

citizens have better health outcomes than average U.S. citizens for several health outcomes, but health outcomes are not always better than those in other developed countries, according to a study published online Dec. from the University of Pennsylvania in Philadelphia, and colleagues compared health outcomes of White U.S.

Development 52

Development Medicine Research 52

XTalks

MARCH 29, 2021

According to a study by researchers at the National Institutes of Health (NIH), moderate caffeine intake could lead to small babies. Grantz, of the Division of Intramural Population Health Research at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Genotype 98

Genotype Allergies Hormones Research 98

Drug Discovery World

SEPTEMBER 28, 2023

This article will focus on one such area of great unmet need and promise: women’s health. Women’s health microbiome-based drug development landscape Despite their limited historical interest, pharma/biotech companies are now increasingly interested in the female microbiome and its role in drug development.

Clinical Trials 64

Clinical Trials Clinical Trials Regulation Bacteria 64

pharmaphorum

JULY 25, 2022

India’s health sector. Government spending on healthcare is still hovering around 1.5%, though there are conscious efforts to improve that with the new schemes launched of universal health care,” Grover says. Targeting maternal mortality. For quite some time, maternal and infant care has been a focus for Philips.

Contamination 122

Contamination Marketing Life Science Engineer 122

The Pharma Data

NOVEMBER 17, 2020

Those that survive often face a lifetime of ill-health including disability, learning difficulties, and visual and hearing problems. As the COVID-19 pandemic overburdens already weak health systems in many countries, it is expected to increase the number of newborn deaths, particularly among babies born too soon.

Nurses 52

Nurses Doctors Doctor Development 52

The Pharma Data

NOVEMBER 24, 2020

24, 2020 — COVID-19 infection during pregnancy does not appear to be associated with adverse maternal or neonatal outcomes, according to a study published online Nov. Six of 188 tested infants had early neonatal SARS-CoV-2 infection and were primarily born to asymptomatic or mildly symptomatic women. TUESDAY, Nov. Adhikari, M.D.,

Development 52

Development Research 52

The Pharma Data

NOVEMBER 15, 2020

New March Of Dimes Report Card Shows Preterm Birth Rates Climb For 5th Straight Year, Earning The Nation A “C-” Grade Humana Foundation and March of Dimes are partnering in six communities nationwide to implement strategies to improve maternal and infant health. . ARLINGTON, Va. , Yet, still in the U.S.

Research 52

Research Development 52

The Pharma Data

NOVEMBER 5, 2020

As health leaders prepare to gather for a virtual session of the resumed 73 rd World Health Assembly (WHA), WHO has three messages to share. Second, we must not backslide on our critical health goals. The COVID-19 pandemic is a sobering reminder that health is the foundation of social, economic and political stability.

Compliance 52

Compliance Containment Regulation Vaccination 52

pharmaphorum

SEPTEMBER 8, 2022

On the strength of phase 2 data, the FDA has awarded coveted breakthrough status to Pfizer’s vaccine against Group B Streptococcus (GBS), given to expectant mothers to prevent invasive infections in newborns and young infants.

Vaccination 52

Vaccination Vaccine Bacterium Licensing 52

The Pharma Data

DECEMBER 31, 2020

31, 2020 — Even the most privileged people in the United States with the best access to health care are sicker and more likely to die than average folks in other developed nations, a new study finds. The new study compared the health outcomes of white U.S. Infant mortality among wealthy white Americans is 3.5

Doctors 52

Doctors Doctor Medicine Development 52

Pfizer

AUGUST 15, 2022

I have started a course of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), I am isolating in place as well as following all public health precautions. There are maternal and fetal risks associated with untreated COVID-19 in pregnancy. Limited published data reports that ritonavir is present in human milk.

Drugs 99

Drugs Vaccination Vaccine In-Vitro 99

The Pharma Data

OCTOBER 15, 2020

A 50 per cent reduction in health services due to the pandemic could cause nearly 200 000 additional stillbirths over a 12-month period in 117 low- and middle-income. According to modeling done for the report by researchers from the Johns Hopkins Bloomberg School of Public Health, 13 countries could see a 20 per cent increase.

Nurses 52

Nurses Research 52

Pfizer

JANUARY 27, 2023

Pregnancy: There are no available human data on the use of nirmatrelvir during pregnancy to evaluate for a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. There are maternal and fetal risks associated with untreated COVID-19 in pregnancy.

Marketing 75

Marketing Production Drugs Licensing 75

Medical Xpress

JANUARY 21, 2023

Maternal health outcomes continue to worsen in the United States, where maternal and infant mortality rates far exceed rates in European countries and other wealthy nations.

Research 132

Research 132

Pfizer

NOVEMBER 14, 2022

Listen Now—The Antigen Season 3 Explores Maternal Immunization. Listen Now—The Antigen Season 3 Explores Maternal Immunization. The Antigen , Pfizer’s flagship podcast returns with a three-part mini-series spotlighting maternal immunization. We’ll also explore the challenges of maternal immunization and what the future holds.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

XTalks

JUNE 5, 2023

A vaccine to help prevent RSV had been an elusive public health goal for more than half a century. The application, aimed at RSVpreF, is intended for both older adults and maternal immunization to protect against RSV and is under accelerated assessment. percent in infants and children up to 24 months of age.

Vaccination 98

Vaccination Vaccine FDA Approval Protein 98

Pfizer

DECEMBER 13, 2022

Pregnancy: There are no available human data on the use of nirmatrelvir during pregnancy to evaluate for a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. There are maternal and fetal risks associated with untreated COVID-19 in pregnancy.

Drugs 110

Drugs Licensing Licensing Production 110

Pharmaceutical Technology

FEBRUARY 1, 2023

A major breakthrough from the National Institutes of Health (NIH), in mapping the structure of the RSV protein significantly changed the landscape, allowing companies to leap into RSV drug research with better efficacy results. Janet Englund, professor of Paediatric Infectious diseases at the University of Washington.

Vaccination 162

Vaccination Vaccine Antibody FDA Approval 162

pharmaphorum

JUNE 28, 2021

AstraZeneca and Sanofi now have the data they need in hand to press ahead with regulatory filings next year for nirsevimab, an antibody designed to prevent respiratory syncytial virus (RSV) – the leading cause of hospitalisations in infants. . If approved, nirsevimab would provide a new option for managing RSV. billion) product at its peak.

Antibody 60

Antibody Trials Sales Branding 60

The Pharma Data

MARCH 3, 2022

The FDA decision is informed by the results of the Phase 2b proof-of-concept study of RSVpreF (NCT04032093), a global, double-blinded, placebo-controlled study that assessed the safety and immunogenicity of RSVpreF in healthy pregnant women ages 18 through 49 years old, who were vaccinated between 28- and 36-weeks gestation, and their infants.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

XTalks

MAY 5, 2023

While most people recover within a couple of weeks, infants and older adults are at a higher risk of severe complications. In a Phase III trial, Pfizer’s maternal RSV vaccine candidate RSVpreF showed 81.8 percent efficacy against severe lower respiratory tract illness due to RSV in infants through the first 90 days of life.

Vaccination 105

Vaccination Vaccine FDA Approval Development 105

Pfizer

JANUARY 27, 2023

This work is undertaken once a new variant of concern has been identified by public health authorities. There are maternal and fetal risks associated with untreated COVID-19 in pregnancy. There is no information on the effects of ritonavir on the breastfed infant or the effects of the drug on milk production.

Research 112

Research Vaccination Vaccine Drugs 112

Pfizer

DECEMBER 20, 2022

Pregnancy: There are no available human data on the use of nirmatrelvir during pregnancy to evaluate for a drug associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. There are maternal and fetal risks associated with untreated COVID-19 in pregnancy.

Drugs 69

Drugs Licensing Licensing Containment 69

pharmaphorum

JANUARY 5, 2023

The clock has started ticking on the FDA’s review of Sanofi and AstraZeneca’s one-shot antibody to protect newborns and infants from respiratory syncytial virus (RSV), with a decision due in the third quarter – just in time for the 2023/24 RSV season.

Antibody 52

Antibody Vaccination Vaccine Marketing 52

Pfizer

NOVEMBER 23, 2022

This agreement, negotiated with the Health Emergency Preparedness and Response Authority (HERA) of the EC, is in addition to the bilateral agreements Pfizer has previously signed with 17 EU Member States. . associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. associated risk of miscarriage.

Licensing 40

Licensing Licensing Drugs Manufacturing 40

STAT News

MARCH 30, 2023

It also leaves the door open for insurers to refuse coverage of statins, drugs preventing HIV transmission known as PrEP, and a vast range of health screenings recommended by federal officials.   Read the rest…

Drugs 137

Drugs 137

The Pharma Data

DECEMBER 8, 2020

National Library of Medicine at the National Institutes of Health, about 100,000 people are affected in the United States , and 30,000 to 40,000 new cases are diagnosed each year. However, pulmonary arterial hypertension is associated with an increased risk of maternal and fetal mortality. According to the U.S. INDICATION. .

Drugs 40

Drugs FDA Approval Marketing Containment 40

The Pharma Data

OCTOBER 21, 2020

The phase 3, multicenter, randomized, double-blind, placebo-controlled, 16-week, parallel group INCREASE study evaluated Tyvaso in adult patients suffering from World Health Organization (WHO) Group 3 PH-ILD. However, pulmonary arterial hypertension is associated with an increased risk of maternal and fetal mortality. INDICATION. .

Production 52

Production Drugs Containment Bioinformatics 52

The Pharma Data

JUNE 28, 2021

Information about the registry can be obtained by calling 1-877-311-8972 or visiting [link] Lactation: There are no data on the presence of apremilast or its metabolites in human milk, the effects of apremilast on the breastfed infant, or the effects of the drug on milk production.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Dermatology 52

pharmaphorum

NOVEMBER 6, 2022

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. In the MELODY trial, Beyfortus reduced the incidence of medically attended lower respiratory tract infections (LRTI) caused by RSV by 74.5%

Antibody 62

Antibody Vaccination Vaccine Sales 62

The Pharma Data

JULY 21, 2021

Leaders from these companies, organizations, and learning institutions have signed a pledge to co-develop programs focused on building trust in the health care system with communities of color and making measurable progress towards health equity. At Novartis, we envision a world with equity in health for all.

Medicine 52

Medicine Clinical Trials Clinical Trials Trials 52

The Pharma Data

SEPTEMBER 2, 2021

4,5 Infections occur in people of all ages and can feel like the common cold for most young adults, but for infants, the immunocompromised, and older adults, it can be potentially life-threatening. Respiratory syncytial virus (RSV) is a common and pervasive cause of acute respiratory illness. 2 In the U.S., About RSVpreF.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

The Pharma Data

APRIL 25, 2021

Nirsevimab demonstrate d protect ion against respiratory syncytial virus disease in healthy infants in Phase 3 trial. Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization in all infants. RSV is the most common cause of LRTI and the leading cause of hospitalizations in all infants. 1 – 5.

Trials 40

Trials Development Medicine Production 40